Table 2.

Prognostic scoring systems in SM

ParameterREMA (for ISM)MAPSIPSMMARSGPS
OSPFSNonadvancedAdvancedOSPFS
WHO (advSM)   +      
Age ≥60 y   + + + +   
Anemia, g/dL         
 ≤10      +   
 ≤11     +  +  
Thrombocytopenia, × 109/L         
 <100     + +  + 
 <150   +      
Leukocytosis, × 109/L         
 ≥16     +    
Increased serum markers         
 Baseline serum tryptase     +   + 
 β2-microglobulin  +      + 
 Alkaline phosphatase   + +   +  
Genetics         
 BM KIT D816V VAF ≥1%  +       
 Additional somatic mutations + (A/R/D+ (A/R/D+ (A/R/NRAS  + (S/A/R+ (S/A/R/D 
ParameterREMA (for ISM)MAPSIPSMMARSGPS
OSPFSNonadvancedAdvancedOSPFS
WHO (advSM)   +      
Age ≥60 y   + + + +   
Anemia, g/dL         
 ≤10      +   
 ≤11     +  +  
Thrombocytopenia, × 109/L         
 <100     + +  + 
 <150   +      
Leukocytosis, × 109/L         
 ≥16     +    
Increased serum markers         
 Baseline serum tryptase     +   + 
 β2-microglobulin  +      + 
 Alkaline phosphatase   + +   +  
Genetics         
 BM KIT D816V VAF ≥1%  +       
 Additional somatic mutations + (A/R/D+ (A/R/D+ (A/R/NRAS  + (S/A/R+ (S/A/R/D 

Adapted from Muñoz-González and Orfao85  with permission.

A, ASXL1; D, DNMT3A; GPS, global prognostic scoring system; R, RUNX1; S, SRSF2.

Close Modal

or Create an Account

Close Modal
Close Modal